Back to top
more

Magellan Health, Inc. (MGLN)

(Delayed Data from NSDQ)

$76.77 USD

76.77
212,253

+0.57 (0.75%)

Updated Nov 21, 2019 03:56 PM ET

Add to portfolio

4-Sell       4  

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.62%
17.69%
9.40%
5.11%
2.01%
10.65%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

A Value | A Growth | B Momentum | A VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Magellan Health (MGLN) Lags Q3 Earnings Estimates

Magellan Health (MGLN) delivered earnings and revenue surprises of -3.15% and 2.78%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

MGLN

Zacks Equity Research

Analysts Estimate Magellan Health (MGLN) to Report a Decline in Earnings: What to Look Out for

Magellan Health (MGLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MGLN

Zacks Equity Research

Why Is Magellan Health (MGLN) Down 12.5% Since Last Earnings Report?

Magellan Health (MGLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MGLN

Zacks Equity Research

Magellan Healths Growth Measures Aid Investors' Confidence

Magellan Health's (MGLN) initiatives to add new business and reduce cost of goods sold aid growth.

CI MGLN UNH MOH

Zacks Equity Research

Magellan Health (MGLN) Q2 Earnings Beat Estimates, Down YoY

Magellan Healths (MGLN) Q2 earnings reflect a pickup in its business, which should aid its performance in the second half.

MGLN UNH ANTM WCG

Zacks Equity Research

Magellan Health (MGLN) Beats Q2 Earnings and Revenue Estimates

Magellan Health (MGLN) delivered earnings and revenue surprises of 3.61% and 2.54%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

MGLN

Zacks Equity Research

Magellan Health (MGLN) to Post Q2 Earnings: What's in Store?

Magellan Health (MGLN) is likely to benefit from its Healthcare segment, partly offset by rise in expenses.

MGLN MOH WCG HCA

Zacks Equity Research

Magellan Health (MGLN) Gains As Market Dips: What You Should Know

Magellan Health (MGLN) closed at $67.40 in the latest trading session, marking a +0.45% move from the prior day.

MGLN

Zacks Equity Research

Should Value Investors Buy Magellan Health (MGLN) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MGLN

Zacks Equity Research

Top Ranked Growth Stocks to Buy for July 22nd

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 22nd

MRK MGLN EBAY ABC

Zacks Equity Research

Analysts Estimate Magellan Health (MGLN) to Report a Decline in Earnings: What to Look Out for

Magellan Health (MGLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MGLN

Zacks Equity Research

Ensign Group (ENSG) Soars to 52-Week High, Time to Cash Out?

Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

ENSG MOH MGLN MEDP

Benjamin Rains

Is UnitedHealth (UNH) Stock a Buy Heading into Q2 2019 Earnings?

Shares of UnitedHealth Group (UNH) popped Friday after they surged Thursday to help spur the Dow Jones Industrial Average's rally. But should investors consider buying UNH stock ahead of its Q2 earnings results?

UNH MOH ANTM MGLN

Mitchell Moore

3 Health-Insurance Stocks to Consider When the Fed Drops Rates

The next Federal Reserve Open Market Committee meeting is set for July 30-31, where they will decide whether or not to cut interest rates. The market assumes a 100% probability that the Fed cuts rates by at least a quarter point, according to analysts.

BCS MGLN MOH UNH

Zacks Equity Research

Is Magellan Health (MGLN) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MGLN

Zacks Equity Research

Magellan Health Mulls Over Possible Sale to Centerbridge

Magellan Health (MGLN) in talks for a possible sale to Centerbridge after its subdued performance.

CNC ANTM MGLN UNH

Zacks Equity Research

UnitedHealth to Buy Equian & Foray into Healthcare Payments

UnitedHealth (UNH) is mulling to buy Equian and enter into the expanding healthcare payments space, as per sources.

JPM MGLN MOH UNH

Zacks Equity Research

Zacks.com featured highlights include: Rent-A-Center, Aaron's, Casey's, Magellan Health and NorthWestern

Zacks.com featured highlights include: Rent-A-Center, Aaron's, Casey's, Magellan Health and NorthWestern

NWE AAN RCII MGLN CASY

Nilanjan Banerjee

Tackle Market Volatility With These 5 Low-Beta Stocks

By considering several parameters, we create an investment strategy to show that less-risky stocks can also fetch handsome returns.

NWE AAN RCII MGLN CASY

Zacks Equity Research

Why Should You Add Magellan Health to Your Portfolio?

Banking high on wise strategic measures and a favorable operating performance, Magellan Health (MGLN) can be added to your portfolio.

WCG MGLN MOH HCA

Tirthankar Chakraborty

Wall Street Foresees a Fed Rate Cut: Winners & Losers

Some analysts have started to price in "insurance cuts," which means they are expecting the Fed to cut rates right before a downturn in order to save the economy.

BAC GS CSII RGEN MGLN MOH

Zacks Equity Research

MGLN vs MOH: Which Health Insurance Stock is Placed Better?

Molina Healthcare (MOH) and Magellan Health (MGLN) are poised to grow in the expanding health insurance industry. Here we try to figure out which stock is positioned better.

MOH JYNT WCG MGLN

Tirthankar Chakraborty

U.S. Service Sector Expands at a Brisk Pace: Top 5 Winners

The U.S. service sector grows faster in May defying slowdown in economic growth and rising trade tensions.

FBIZ MGLN HCA CMG BBSI

Zacks Equity Research

Why Is Magellan Health (MGLN) Down 2.4% Since Last Earnings Report?

Magellan Health (MGLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MGLN

Sapna Bagaria

4 Stocks to Buy Despite Year-to-Date Fall in Health Insurance

Despite regulatory noise, strong fundamentals and changing demographics of the country poise health insurance stocks for growth.

MGLN MOH WCG JYNT